genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
Astex Pharmaceuticals
Cancer
Supportive Care: OnQuality Treats Cancer’s Side Effects
Cancer
Merck & Co. Launches Up-to-$2.5B Cancer Collaboration with Taiho, Astex
Cancer
Otsuka/Astex AML Candidate Guadecitabine Fails Phase III Trial
Industry News
Otsuka Acquires Astex for $866M
Cancer
EC Clears Dacogen for AML in the Over-65s
Cancer
Astex Pulls Plug on Phase II Anticancer Drug
Cancer
Astex Transfers Anticancer Epigenetics Collaboration to Partner GSK
Cancer
SuperGen to Merge with Astex for $25M in Cash
Cancer
Astex Signs CRADA with NCI to Investigate Its Small Molecule Therapeutic
Cancer
Astex Taps Cancer Research UK to Carry Out Early-Stage Trials
1
2
Page 1 of 2
Scroll Up
Scroll Up
